China National Center for Cardiovascular Diseases: Not applicable (device, behavioral) study in Ventricular Tachycardia (VT), Ischemic Cardiomyopathy (526 participants)
China National Center for Cardiovascular Diseases: Not applicable (device, behavioral) study in Ventricular Tachycardia (VT), Ischemic Cardiomyopathy (526 participants). Its enrollment of 526 is top-decile (90th percentile of 8,879 records). Dated 9 days ago, it is in the active follow-up window. Score 65/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 526 · 90th percentile of 8,879 ClinicalTrialStartPulse records · 6.6x the median
Free preview: all 14 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | China National Center for Cardiovascular Diseases |
| Sponsor type | Non-US government |
| Study | MRI-guided Ventricular Tachycardia Ablation in Patients With Structural Heart Disease |
| NCT ID | NCT07896980 |
| Phase | Not applicable (device, behavioral) |
| Status | not yet recruiting |
| Conditions | Ventricular Tachycardia (VT); Ischemic Cardiomyopathy; Non-ischemic Cardiomyopathy |
| Intervention types | procedure |
| Target enrollment | 526 |
| Site countries | China |
| Posted | 2026-10-27 |
| Planned start | 2026-10-01 |
| Event | Newly registered study |
| Event date | 2026-10-27 |
| enrollment percentile | 90th of 8,879 (median 80, 6.6x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch China National Center for Cardiovascular Diseases
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock China National Center for Cardiovascular Diseases + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-27
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: China National Center for Cardiovascular Diseases and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- China National Center for Cardiovascular Diseases's enrollment: 90th percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
65 / 100 Score
- Posted in the last two weeks.
- 526 participants planned.
- Not yet recruiting: vendors still being chosen.
What is the ClinicalTrialStartPulse record for China National Center for Cardiovascular Diseases?
China National Center for Cardiovascular Diseases registered a Not applicable (device, behavioral) study (NCT07896980) in Ventricular Tachycardia (VT) targeting 526 participants, posted 2026-10-27.
How does China National Center for Cardiovascular Diseases compare to other ClinicalTrialStartPulse records?
This is a top-decile record: its enrollment of 526 is 6.6x the median of 80 across 8,879 records. It is fresh: dated 9 days ago, inside the window where early outreach matters most.
China National Center for Cardiovascular Diseases vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| China National Center for Cardiovascular Diseases | NONUS | 526 | 90th | 2026-10-27 |
| Galderma R&D | NONUS | 326 | 84th | 2026-11-02 |
| Galderma R&D | NONUS | 162 | 72nd | 2026-11-03 |
| A.M.I. Agency for Medical Innovations GmbH | NONUS | 100 | 60th | 2026-10-30 |
Related records
ClinicalTrialStartPulse: Not applicable (device, behavioral) ClinicalTrialStartPulse: Outside the US only
How to monitor China National Center for Cardiovascular Diseases and peer not applicable (device, behavioral) records
Get new ClinicalTrialStartPulse records like China National Center for Cardiovascular Diseases by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.